{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:45:21Z","timestamp":1765521921112,"version":"3.48.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2589203","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:56:32Z","timestamp":1762948592000},"page":"992-1001","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["An analysis of causality assessed serious and severe adverse events following COVID-19 vaccines administered from January 2021 to September 2022 in India"],"prefix":"10.1080","volume":"24","author":[{"given":"Awnish Kumar","family":"Singh","sequence":"first","affiliation":[{"name":"University of Michigan","place":["Ann Arbor, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neneh","family":"Feren","sequence":"additional","affiliation":[{"name":"Kasturba Medical College","place":["Mangalore, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Thapar","sequence":"additional","affiliation":[{"name":"Kasturba Medical College","place":["Mangalore, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Boulton","sequence":"additional","affiliation":[{"name":"University of Michigan","place":["Ann Arbor, USA"]},{"name":"University of Michigan","place":["Ann Arbor, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-020-00671-y"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.01.118"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1108\/IJHG-07-2021-0072"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3772401"},{"volume-title":"Risks of non-vaccination","year":"2020","key":"e_1_3_5_7_1","unstructured":"Risks of non-vaccination. Elsevier Masson SAS; 2020."},{"key":"e_1_3_5_8_1","unstructured":"WHO COVID 19 dashboard. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o"},{"volume-title":"AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges, and solutions in Nepal","year":"2021","key":"e_1_3_5_9_1","unstructured":"AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges, and solutions in Nepal. Elsevier Inc; 2021."},{"key":"e_1_3_5_10_1","unstructured":"COVID 19 vaccination worldwide. Available from: https:\/\/ourworldindata.org\/grapher\/covid-people-vaccinated-marimekko?tab=table"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-60502-4_6"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00327-2"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n978"},{"key":"e_1_3_5_14_1","unstructured":"Approved COVID-19 vaccines as on 26.07.2023. 2023."},{"key":"e_1_3_5_15_1","article-title":"Adverse events following immunization and assessment of causality","author":"Wodi T","year":"2021","unstructured":"Wodi T, Patricia A, Shimabukuro. Adverse events following immunization and assessment of causality. Pink Book Centers Dis Control Prev. 2021.","journal-title":"Pink Book Centers Dis Control Prev"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-017-2532-9"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.027"},{"key":"e_1_3_5_18_1","volume-title":"Causality assessment of an adverse event following immunization (AEFI) 2018 user manual for the revised WHO classification, second","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI) 2018 user manual for the revised WHO classification, second. 2018."},{"key":"e_1_3_5_19_1","first-page":"13","volume-title":"Global manual on surveillance of adverse events following immunization","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Adverse events following immunization. In: Global manual on surveillance of adverse events following immunization. Geneva: World Health Organization; 2014. p. 13."},{"key":"e_1_3_5_20_1","volume-title":"Global vaccine safety blueprint - landscape analysis","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Global vaccine safety blueprint - landscape analysis. Geneva: World Health Organization; 2012."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7015a2"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.01.100"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116181"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.013"},{"volume-title":"Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis","year":"2021","key":"e_1_3_5_25_1","unstructured":"Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis. Elsevier B.V; 2021."},{"volume-title":"India\u2019s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review","year":"2022","key":"e_1_3_5_26_1","unstructured":"India\u2019s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review. Korea Centers for Disease Control and Prevention; 2022."},{"key":"e_1_3_5_27_1","volume-title":"COVID-19 vaccines operational guidelines","author":"MoHFW Govt. of India","year":"2020","unstructured":"MoHFW Govt. of India. COVID-19 vaccines operational guidelines. New Delhi: Ministry of Health and Family Welfare, Government of India; 2020."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e220"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11060955"},{"key":"e_1_3_5_30_1","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI) user manual for the revised WHO classification. 2019."},{"key":"e_1_3_5_31_1","unstructured":"MoHFW Govt. of India. AEFI_Surveillance_and_Response_Operational_Guidelines_2015. New Dlehi: Ministry of Health and Family Welfare Government of India; 2015."},{"volume-title":"RStudio: integrated development environment for R","year":"2024","key":"e_1_3_5_32_1","unstructured":"RStudio: integrated development environment for R. Boston. 2024."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27655"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.4103\/mjdrdypu.mjdrdypu_428_22"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2023.02.004"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.7326\/M21-4502"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3126\/jpahs.v8i1.36242"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7018e3"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030441"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.11606\/s1518-8787.2021055003734"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53845"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2589203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:41:25Z","timestamp":1765521685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2589203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2589203"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2589203","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"type":"print","value":"1476-0584"},{"type":"electronic","value":"1744-8395"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}